Replies to post #217386 on Biotech Values

[DewDiligence]

Can PTLA get new patents from new indications from future FDA approvals, like atrial fibrillation and hip or knee replacement surgery?

If PTLA doesn't already have such method-of-use patents, they won't be able to get them now. The efficacy of FXa inhibitors in these indications is already well known, and hence a new patent application would fail due to obviousness.